多中心比较三种MOG-IgG细胞学检测方法
该研究比较了来自三个国际中心的三种髓鞘少突胶质细胞糖蛋白免疫球蛋白G(MOG-IgG)细胞学检测方法(CBA)。对394例患者血清样本检测显示,三种方法总体一致性高,但活细胞法阳性预测值优于固定细胞法,提示活细胞法阳性结果对MOG抗体相关疾病谱更具可靠性。
要点
- 三种MOG-IgG CBA检测总体一致性高,25例阳性中21例三种方法均阳性。
- 活细胞法(Mayo和Oxford)阳性预测值高于固定细胞法(Euroimmun)。
- 固定细胞法假阳性较多,5例假阳性中4例仅Euroimmun阳性。
核心结论
- 三种MOG-IgG CBA检测方法总体一致性高,活细胞法阳性预测值优于固定细胞法,阳性结果更可靠提示MOG抗体相关疾病谱。
研究设计与样本
- 多中心比较研究,纳入394例患者血清样本,包括急性播散性脑脊髓炎28例、血清阴性视神经脊髓炎27例、视神经炎21例单相和2例复发、长节段横贯性脊髓炎10例单相和3例复发,对照为多发性硬化244例、高丙种球蛋白血症42例和其他17例。
主要发现
- 25例样本经任一方法检测阳性,其中21例三种方法均一致阳性,2例Oxford和Euroimmun阳性,2例仅Oxford阳性。
- Euroimmun、Mayo和Oxford的临床特异性分别为98.1%、99.6%和100%,阳性预测值分别为82.1%、95.5%和100%,阴性预测值分别为79.0%、78.8%和79.8%。
- 5例假阳性中,1例Euroimmun和Mayo均阳性,4例仅Euroimmun阳性。
关键数值与推荐
- Euroimmun固定CBA临床特异性98.1%,阳性预测值82.1%,阴性预测值79.0%。
- Mayo活细胞FACS检测临床特异性99.6%,阳性预测值95.5%,阴性预测值78.8%。
- Oxford活细胞CBA临床特异性100%,阳性预测值100%,阴性预测值79.8%。
临床怎么用
- 临床怀疑MOG抗体相关疾病时,优先选择活细胞法CBA检测,其阳性预测值更高,阳性结果更可靠。
- 固定细胞法CBA阳性结果需谨慎解读,假阳性风险较高,可结合临床和其他检测方法综合判断。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To compares 3 different myelin oligodendrocyte glycoprotein-immunoglobulin G (IgG) cell-based assays (CBAs) from 3 international centers. METHODS: Serum samples from 394 patients were as follows: acute disseminated encephalomyelitis (28), seronegative neuromyelitis optica (27), optic neuritis (21 single, 2 relapsing), and longitudinally extensive (10 single, 3 recurrent). The control samples were from patients with multiple sclerosis (244), hypergammaglobulinemia (42), and other (17). Seropositivity was determined by visual observation on a fluorescence microscope (Euroimmun fixed CBA, Oxford live cell CBA) or flow cytometry (Mayo live cell fluorescence-activated cell sorting assay). RESULTS: Of 25 samples positive by any methodology, 21 were concordant on all 3 assays, 2 were positive at Oxford and Euroimmun, and 2 were positive only at Oxford. Euroimmun, Mayo, and Oxford results were as follows: clinical specificity 98.1%, 99.6%, and 100%; positive predictive values (PPVs) 82.1%, 95.5%, and 100%; and negative predictive values 79.0%, 78.8%, and 79.8%. Of 5 false-positives, 1 was positive at both Euroimmun and Mayo and 4 were positive at Euroimmun alone. CONCLUSIONS: Overall, a high degree of agreement was observed across 3 different MOG-IgG CBAs. Both live cell-based methodologies had superior PPVs to the fixed cell assays, indicating that positive results in these assays are more reliable indicators of MOG autoimmune spectrum disorders.
引用
- Waters PJ, Komorowski L, Woodhall M, et al. A multicenter comparison of MOG-IgG cell-based assays. Neurology. 2019. PMID: 30728305. doi:10.1212/WNL.0000000000007096
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。